Medistim ASA (FRA:MD1) Cyclically Adjusted FCF per Share: €0.55 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:MD1 Medistim ASA FRA:MD1
100 GF Score
Price €20.20
GF Value €23.15
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Medistim ASA Cyclically Adjusted FCF per Share?

Medistim ASA FRA:MD1 -3.81% 100 Cyclically Adjusted FCF per Share is €0.55 as of Mar. 2026. GuruFocus rates FRA:MD1 with a GF Score™ of 100/100 and a GF Value™ of €23.15 (Modestly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Medistim ASA's adjusted free cash flow per share for the three months ended in Mar. 2026 was €0.035. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €0.55 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Medistim ASA's average Cyclically Adjusted FCF Growth Rate was 16.60% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 14.30% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 16.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Medistim ASA was 19.50% per year. The lowest was 9.00% per year. And the median was 14.70% per year.

As of today (2026-07-19), Medistim ASA's current stock price is €20.20. Medistim ASA's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was €0.55. Medistim ASA's Cyclically Adjusted Price-to-FCF of today is 36.73.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Medistim ASA was 126.33. The lowest was 25.93. And the median was 49.78.


Medistim ASA  (FRA:MD1) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Medistim ASA's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=20.20/0.55
=36.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Medistim ASA was 126.33. The lowest was 25.93. And the median was 49.78.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Medistim ASA Cyclically Adjusted FCF per Share Related Terms


Medistim ASA Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Medistim ASA's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medistim ASA Cyclically Adjusted FCF per Share Chart

Medistim ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.37 0.39 0.44 0.45 0.52

Medistim ASA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.47 0.47 0.50 0.52 0.55

FRA:MD1 vs ABT, SYK, MDT: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Medistim ASA's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medistim ASA Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medistim ASA's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Medistim ASA's Cyclically Adjusted Price-to-FCF falls into.


FRA:MD1
100GF Score
Medistim ASA FRA:MD1
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medistim ASA Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medistim ASA's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.035/141.0300*141.0300
=0.035

Current CPI (Mar. 2026) = 141.0300.

Medistim ASA Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.039 103.800 0.053
201609 0.050 104.200 0.068
201612 0.098 104.400 0.132
201703 0.082 105.000 0.110
201706 -0.011 105.800 -0.015
201709 0.078 105.900 0.104
201712 0.205 106.100 0.272
201803 0.037 107.300 0.049
201806 0.028 108.500 0.036
201809 0.109 109.500 0.140
201812 0.142 109.800 0.182
201903 0.062 110.400 0.079
201906 0.106 110.600 0.135
201909 0.128 111.100 0.162
201912 0.152 111.300 0.193
202003 0.109 111.200 0.138
202006 0.092 112.100 0.116
202009 0.071 112.900 0.089
202012 0.102 112.900 0.127
202103 0.098 114.600 0.121
202106 0.116 115.300 0.142
202109 0.224 117.500 0.269
202112 0.249 118.900 0.295
202203 0.126 119.800 0.148
202206 0.147 122.600 0.169
202209 0.164 125.600 0.184
202212 0.171 125.900 0.192
202303 0.003 127.600 0.003
202306 0.147 130.400 0.159
202309 0.200 129.800 0.217
202312 0.214 131.900 0.229
202403 0.105 132.600 0.112
202406 0.121 133.800 0.128
202409 0.140 133.700 0.148
202412 0.297 134.800 0.311
202503 0.089 136.100 0.092
202506 0.178 137.800 0.182
202509 0.324 138.500 0.330
202512 0.305 139.100 0.309
202603 0.035 141.030 0.035

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €0.55 mean?
Medistim ASA (FRA:MD1) has a Cyclically Adjusted FCF per Share of €0.55 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Medistim ASA and its competitors.
Is Medistim ASA's Cyclically Adjusted FCF per Share too high?
Medistim ASA's current Cyclically Adjusted FCF per Share is €0.55. Overall, Medistim ASA has a GF Score™ of 100/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medistim ASA's Cyclically Adjusted FCF per Share compare to ABT and SYK?
Medistim ASA's Cyclically Adjusted FCF per Share of €0.55 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Medistim ASA and its competitors. Medistim ASA's current Cyclically Adjusted FCF per Share is €0.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medistim ASA stock overvalued right now?
Based on GuruFocus' analysis, Medistim ASA (FRA:MD1) is currently considered Modestly Undervalued. The stock's GF Value™ is €23.15, compared to a current price of €20.20 — trading 12.7% below its estimated fair value. The current Cyclically Adjusted FCF per Share is €0.55. Medistim ASA's overall GF Score™ is 100/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Medistim ASA (FRA:MD1), the current Cyclically Adjusted FCF per Share is €0.55 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medistim ASA (FRA:MD1) Overvalued in 2026?

Based on GuruFocus' analysis, Medistim ASA stock appears to be undervalued. The current stock price of €20.20 is trading 12.7% below its estimated GF Value™ of €23.15. GuruFocus considers Medistim ASA to be Modestly Undervalued.

Key valuation signals for FRA:MD1:

  • Cyclically Adjusted FCF per Share: €0.55
  • GF Value™: €23.15 vs. price of €20.20 (12.7% below fair value)
  • GF Score™: 100/100 with 1 warning sign

No single metric tells the full story. See the FRA:MD1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medistim ASA Business Description

Address Okernveien 94, Oslo, NOR, 0579
Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing, and sales of medical equipment through its own business or participation in other companies, as well as related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, China, and the Rest of the World. The main divisions are sale of own products and sale of third-party products. Sale of own products has two business models, the capital model and the lease model. Third-party products segment sells medical devices from third party manufacturers in Norway, Sweden and Denmark. Key revenue is generated from Own Products segment.
100GF Score

Get the complete analysis for FRA:MD1

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€20.20
Price
€23.15
GF Value